[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"x-linked-retinitis-pigmentosa\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:x-linked-retinitis-pigmentosa":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100506432","early-phase-1-gene-therapy-for-subjects-with-rpgr-mutation-associated-x-linked-retinitis-pigmentosa-100506432",false,"NCT05874310","Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa","An Open-label, Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intraocular Administration of FT-002 in Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa.","Inclusion Criteria:\n\n1.Subjects that are willing and able to follow study procedures; 2.Males aged 8-45 years old at the time of signing the Informed Consent Form; 4.Subjects who are confirmed with variants of RPGR ;\n\nExclusion Criteria:\n\n1.Have other retinal degenerative diseases, such as retinal degeneration caused by other known Inherited retinal disease gene variants or previously received an gene therapy product.","MALE","8 Years","45 Years",{"count":20,"type":21},18,"ESTIMATED","INTERVENTIONAL",[24],"EARLY_PHASE1","A clinical trial of gene therapy for patients with X-linked retinitis pigmentosa (XLRP).",[27],"X-Linked Retinitis Pigmentosa","RECRUITING","2023-05-23",{"date":31,"type":32},"2023-05-24","ACTUAL",{"date":34,"type":32},"2023-02-01",{"date":36,"type":21},"2027-11-01",{"name":38,"class":39},"Frontera Therapeutics","INDUSTRY",2]